ritanserin has been researched along with tertatolol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouysset, F; Laubie, M; Schmitt, H; Vayssettes-Courchay, C; Verbeuren, TJ | 1 |
| Bietti, G; Borsini, F; Ceci, A; Donetti, A | 1 |
2 other study(ies) available for ritanserin and tertatolol
| Article | Year |
|---|---|
The cardiovascular effects of quipazine are mediated by peripheral 5-HT2 and 5-HT3 receptors in anaesthetized rats.
Topics: Amidines; Anesthesia; Animals; Blood Pressure; Carotid Body; Denervation; Heart Rate; Hemodynamics; Hexamethonium Compounds; In Vitro Techniques; Indoles; Lung; Male; Myocardium; Piperidines; Prazosin; Pressoreceptors; Propanolamines; Quipazine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Renin-Angiotensin System; Ritanserin; Sympathetic Nervous System; Thiophenes; Tropisetron; Vagotomy | 1990 |
BIMT 17, a 5-HT1A receptor agonist/5-HT2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral cortex.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Antidepressive Agents; Benzimidazoles; Binding, Competitive; Buspirone; Cerebral Cortex; Dose-Response Relationship, Drug; In Vitro Techniques; Iontophoresis; Male; Microelectrodes; Neurons; Piperazines; Prazosin; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Ritanserin; Serotonin Antagonists; Serotonin Receptor Agonists; Thiophenes | 1995 |